| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9110
Address all correspondence and requests for reprints to: Dr. Jer-Tsong Hsieh, Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9110. E-mail: hsieh{at}utsw.swmed.edu
Androgen is a mitogen as well as a morphogen for prostatic epithelium. However, the detailed mechanisms of these distinct androgenic actions have not yet been delineated. Therefore, we employed differential display PCR to unveil any potential genes that may be involved in these processes. In this study, we report the isolation and characterization of two alternative splicing forms (p82 and p59) of C9 complementary DNA, the rat homolog of the human deletion of ovarian carcinoma 2 (DOC-2) gene and mouse p96 phosphoprotein, from rat ventral prostate (VP). We found that C9 was up-regulated in rat VP after castration, suggesting that C9 may be regulated by androgen receptor directly or indirectly during prostate degeneration. A similar regulatory pattern was also observed in both the seminal vesicle and dorsolateral prostate, but not in the coagulating gland or other androgen-independent organs. Immunohistochemical analysis of rat VP demonstrated that C9 is detected in the basal epithelia and surrounding stromal cells after prolonged castration. Ribonuclease protection assay and Western blot analysis revealed that p59 is the predominant C9 isoform in rat VP. To unveil the function of C9 in cell growth, we transfected p59 complementary DNA into the C4-2 cells, a derivative of the LNCaP prostatic carcinoma cell line. The p59 stable transfectants exhibited a slower growth rate and an increase in the cell fraction in the G1 phase under our experimental conditions. These data indicate that C9-p59 has growth inhibitory activity for prostatic epithelial cells. Taken together, our results suggest that C9 is up-regulated during prostate degeneration process and may play an active role in the proliferation and differentiation of prostatic epithelium.
This article has been cited by other articles:
 |
|
 |
|
  J.-T. Hsieh, J. A. Karam, and W. Min Genetic and Biologic Evidence that Implicates a Gene in Aggressive Prostate Cancer J Natl Cancer Inst, December 19, 2007; 99(24): 1823 - 1824. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Holmes, A. Flett, D. Coudreuse, H. C. Korswagen, and J. Pettitt C. elegans Disabled is required for cell-type specific endocytosis and is essential in animals lacking the AP-3 adaptor complex J. Cell Sci., August 1, 2007; 120(15): 2741 - 2751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Karam, S. F. Shariat, H.-Y. Huang, R.-C. Pong, R. Ashfaq, E. Shapiro, Y. Lotan, A. I. Sagalowsky, X.-R. Wu, and J.-T. Hsieh Decreased DOC-2/DAB2 Expression in Urothelial Carcinoma of the Bladder Clin. Cancer Res., August 1, 2007; 13(15): 4400 - 4406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Romero, L. L. Yanes, A. F. de Rodriguez, M. W. Plonczynski, B. L. Welsh, J. F. Reckelhoff, E. P. Gomez-Sanchez, and C. E. Gomez-Sanchez Disabled-2 Is Expressed in Adrenal Zona Glomerulosa and Is Involved in Aldosterone Secretion Endocrinology, June 1, 2007; 148(6): 2644 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Kumbar, A. VanBergen, C. Ocampo, S. Muangmingsuk, A. J. Griffin, and M. Gupta Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts J Appl Physiol, May 1, 2007; 102(5): 2024 - 2032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Huang, J.-C. Cheng, A. Stern, J.-T. Hsieh, C.-H. Liao, and C.-P. Tseng Disabled-2 is a novel {alpha}IIb-integrin-binding protein that negatively regulates platelet-fibrinogen interactions and platelet aggregation J. Cell Sci., November 1, 2006; 119(21): 4420 - 4430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-C. Pong, R. Roark, J.-Y. Ou, J. Fan, J. Stanfield, E. Frenkel, A. Sagalowsky, and J.-T. Hsieh Mechanism of Increased Coxsackie and Adenovirus Receptor Gene Expression and Adenovirus Uptake by Phytoestrogen and Histone Deacetylase Inhibitor in Human Bladder Cancer Cells and the Potential Clinical Application. Cancer Res., September 1, 2006; 66(17): 8822 - 8828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-H. Yang, Z. Fazili, E. R. Smith, K. Q. Cai, A. Klein-Szanto, C. Cohen, I. R. Horowitz, and X.-X. Xu Disabled-2 Heterozygous Mice Are Predisposed to Endometrial and Ovarian Tumorigenesis and Exhibit Sex-Biased Embryonic Lethality in a p53-Null Background Am. J. Pathol., July 1, 2006; 169(1): 258 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhoul, G. Hernandez, S.-W. Tu, C.-L. Huang, C.-P. Tseng, and J.-T. Hsieh The Role of DOC-2/DAB2 in Modulating Androgen Receptor-Mediated Cell Growth via the Nongenomic c-Src-Mediated Pathway in Normal Prostatic Epithelium and Cancer Cancer Res., November 1, 2005; 65(21): 9906 - 9913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nagai, E. I. Christensen, S. M. Morris, T. E. Willnow, J. A. Cooper, and R. Nielsen Mutually dependent localization of megalin and Dab2 in the renal proximal tubule Am J Physiol Renal Physiol, September 1, 2005; 289(3): F569 - F576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhou, G. Hernandez, S.-w. Tu, J. Scholes, H. Chen, C.-P. Tseng, and J.-T. Hsieh Synergistic Induction of DOC-2/DAB2 Gene Expression in Transitional Cell Carcinoma in the Presence of GATA6 and Histone Deacetylase Inhibitor Cancer Res., July 15, 2005; 65(14): 6089 - 6096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Prunier and P. H. Howe Disabled-2 (Dab2) Is Required for Transforming Growth Factor {beta}-induced Epithelial to Mesenchymal Transition (EMT) J. Biol. Chem., April 29, 2005; 280(17): 17540 - 17548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Huang, J.-C. Cheng, C.-H. Liao, A. Stern, J.-T. Hsieh, C.-H. Wang, H.-L. Hsu, and C.-P. Tseng Disabled-2 Is a Negative Regulator of Integrin {alpha}IIb{beta}3-mediated Fibrinogen Adhesion and Cell Signaling J. Biol. Chem., October 1, 2004; 279(40): 42279 - 42289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Dote, S. Toyooka, K. Tsukuda, M. Yano, M. Ouchida, H. Doihara, M. Suzuki, H. Chen, J.-T. Hsieh, A. F. Gazdar, et al. Aberrant Promoter Methylation in Human DAB2 Interactive Protein (hDAB2IP) Gene in Breast Cancer Clin. Cancer Res., March 15, 2004; 10(6): 2082 - 2089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kihara, M. Ikeda, Y. Kariya, E.-Y. Lee, Y.-M. Lee, and Y. Igarashi Sphingosine-1-phosphate Lyase Is Involved in the Differentiation of F9 Embryonal Carcinoma Cells to Primitive Endoderm J. Biol. Chem., April 11, 2003; 278(16): 14578 - 14585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhou, J. Scholes, and J.-T. Hsieh Characterization of a Novel Negative Regulator (DOC-2/DAB2) of c-Src in Normal Prostatic Epithelium and Cancer J. Biol. Chem., February 21, 2003; 278(9): 6936 - 6941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chen, S. Toyooka, A. F. Gazdar, and J.-T. Hsieh Epigenetic Regulation of a Novel Tumor Suppressor Gene (hDAB2IP) in Prostate Cancer Cell Lines J. Biol. Chem., January 24, 2003; 278(5): 3121 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wang, C.-P. Tseng, R.-C. Pong, H. Chen, J. D. McConnell, N. Navone, and J.-T. Hsieh The Mechanism of Growth-inhibitory Effect of DOC-2/DAB2 in Prostate Cancer. CHARACTERIZATION OF A NOVEL GTPase-ACTIVATING PROTEIN ASSOCIATED WITH N-TERMINAL DOMAIN OF DOC-2/DAB2 J. Biol. Chem., April 5, 2002; 277(15): 12622 - 12631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Smith, C. D. Capo-chichi, J. He, J. L. Smedberg, D.-H. Yang, A. H. Prowse, A. K. Godwin, T. C. Hamilton, and X.-X. Xu Disabled-2 Mediates c-Fos Suppression and the Cell Growth Regulatory Activity of Retinoic Acid in Embryonic Carcinoma Cells J. Biol. Chem., December 7, 2001; 276(50): 47303 - 47310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Okegawa, R.-C. Pong, Y. Li, J. M. Bergelson, A. I. Sagalowsky, and J.-T. Hsieh The Mechanism of the Growth-inhibitory Effect of Coxsackie and Adenovirus Receptor (CAR) on Human Bladder Cancer: A Functional Analysis of CAR Protein Structure Cancer Res., September 1, 2001; 61(17): 6592 - 6600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Steiner, X. Zhang, Y. Wang, and Y. Lu Growth Inhibition of Prostate Cancer by an Adenovirus Expressing a Novel Tumor Suppressor Gene, pHyde Cancer Res., August 1, 2000; 60(16): 4419 - 4425. [Abstract] [Full Text]
|
|
|
|
|
|
C.-P. Tseng, B. D. Ely, R.-C. Pong, Z. Wang, J. Zhou, and J.-T. Hsieh The Role of DOC-2/DAB2 Protein Phosphorylation in the Inhibition of AP-1 Activity. AN UNDERLYING MECHANISM OF ITS TUMOR-SUPPRESSIVE FUNCTION IN PROSTATE CANCER J. Biol. Chem., November 5, 1999; 274(45): 31981 - 31986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, R.-C. Pong, J. M. Bergelson, M. C. Hall, A. I. Sagalowsky, C.-P. Tseng, Z. Wang, and J.-T. Hsieh Loss of Adenoviral Receptor Expression in Human Bladder Cancer Cells: A Potential Impact on the Efficacy of Gene Therapy Cancer Res., January 1, 1999; 59(2): 325 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. He, E. R. Smith, and X.-X. Xu Disabled-2 Exerts Its Tumor Suppressor Activity by Uncoupling c-Fos Expression and MAP Kinase Activation J. Biol. Chem., July 13, 2001; 276(29): 26814 - 26818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhou and J.-T. Hsieh The Inhibitory Role of DOC-2/DAB2 in Growth Factor Receptor-mediated Signal Cascade. DOC-2/DAB2-MEDIATED INHIBITION OF ERK PHOSPHORYLATION VIA BINDING TO Grb2 J. Biol. Chem., July 20, 2001; 276(30): 27793 - 27798. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
